Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Pfizer Inc. (PFE) had Normalized Income after Taxes of $2.97B for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$13.71B |
|
$2.97B |
|
$2.85B |
|
$10.87B |
|
$9.98B |
|
$3.74B |
|
$-953.00M |
|
$2.79B |
|
$2.79B |
|
$2.97B |
|
$2.97B |
|
$2.97B |
|
|
Normalized Income after Taxes |
$2.97B |
$3.74B |
|
-- |
|
5.67B |
|
5.71B |
|
$0.52 |
|
$0.52 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|